Clinical Trials Using Technetium Tc 99m-labeled Tilmanocept
Clinical trials are research studies that involve people. The clinical trials on this list are studying Technetium Tc 99m-labeled Tilmanocept. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Tc-99m Tilmanocept for the Detection of Draining Lymph Nodes
This phase I trial studies how well Tc-99m tilmanocept detects lymph nodes that drain a brain tumor in patients with suspected benign (non-cancerous) or malignant (cancerous) brain tumors. Tc-99m tilmanocept is a radioactive substance that is used to find lymph nodes by injecting it and then scanning the body with a device that can trace its radioactivity. Imaging Tc-99m tilmanocept may help researchers determine if lymph nodes can be detected how long it takes the Tc-99m tilmanocept to travel from the tumor to the lymph nodes in patients with suspected brain tumors.
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients with Head and Neck Cancer
This phase II trial studies how well panitumumab-IRDye800 works in identifying head and neck cancer that has spread to the lymph nodes in patients with head and neck cancer. Panitumumab-IRDye800 may help surgeons to identify metastatic lymph nodes during surgical removal of the primary tumor and / or lymph nodes of the neck with equal or better accuracy than the current methods.
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California